Andrew Pollard: Latest News

All news where Andrew Pollard is mentioned

manchestereveningnews.co.uk

10.08.2021 / 17:53

Seven things we learned from leading Covid scientists today - from 'mythical' herd immunity to 'inevitable' vaccine-escaping variants

Andrew Pollard Britain vaccine infection Coronavirus

Third dose of existing Oxford Covid jab 'could provide further protection'

coronavirus, new research has found. An Oxford University study found that giving people an additional dose six months after the second jab led to a ‘substantial rise’ in antibodies to fight against Covid - without the need to tweak the vaccine.

Andrew Pollard experts vaccine Coronavirus Health

Covid trial finds Oxford-AstraZeneca jab '100% effective against serious symptoms'

trial on the Oxford-AstraZeneca vaccine has found it was 100% effective at preventing serious disease.US researchers gave 32,000 volunteers - a fifth aged over 65 - two doses of the jab, four weeks apart.They found none had to go hospital and only 141 developed symptoms afterwards - suggesting the vaccine was 79% effective at stopping illness in those vulnerable to the virus.Andrew Pollard, the lead investigator of the Oxford University trial of the vaccine, said: "These results are great news as they show the remarkable efficacy of the vaccine in a new population and are consistent with the results from Oxford-led trials."We can expect strong impact against Covid-19 across all ages and for people of all different backgrounds from

Andrew Pollard city Oxford vaccine Volunteers symptoms

manchestereveningnews.co.uk

15.03.2021 / 15:44

74%

675

When will you be offered a Covid-19 vaccine? This calculator gives you an idea

direct to your inbox The government announced it was ramping up its coronavirus vaccination programme last week - offering millions more jabs to adults in the UK as it gradually attempts to ease lockdown restrictions.

Andrew Pollard Britain Netherlands vaccine Government

manchestereveningnews.co.uk

15.03.2021 / 15:13

65%

848

Oxford professor reassures public over AstraZeneca Covid vaccine

direct to your inbox The head of the Oxford University vaccine group has sought to reassure the public over its coronavirus jab after several countries temporarily suspended its use.

Andrew Pollard Thailand Ireland Netherlands Denmark Norway Bulgaria Iceland death vaccine

Clinical trial to begin to test Oxford/AstraZeneca vaccine efficacy among children

The efficacy of the Oxford/AstraZeneca vaccine in children is set to be tested in a new clinical trial.

Andrew Pollard Britain Ireland World Coronavirus

The Latest: Oxford University testing vaccine in children

LONDON — The University of Oxford plans to test its COVID-19 vaccine in children for the first time, becoming the latest vaccine developer to assess whether its coronavirus shot is effective in young people.

Andrew Pollard city Oxford covid-19 testing vaccine

Oxford says AstraZeneca Covid vaccine works against B117 UK variant

coronavirus vaccine has similar efficacy against the UK virus variant as it does to the previously circulating variants, the university has said.Oxford University, which developed the Covid vaccine with the British-Swedish pharmaceutical company, said an ongoing assessment of its effectiveness showed that it has "similar efficacy" to other Covid-19 strains."Data from our trials of the ChAdOx1 vaccine in the United Kingdom indicate that the vaccine not only protects against the original pandemic virus, but also protects against the novel variant, B.1.1.7, which caused the surge in disease from the end of 2020 across the UK," said Andrew Pollard, Chief Investigator on the Oxford vaccine trial.Protection against symptomatic infection was

Andrew Pollard Britain Sweden virus vaccine strain Coronavirus

manchestereveningnews.co.uk

05.02.2021 / 19:26

70%

309

Oxford Covid-19 vaccine does protect against UK strain of coronavirus, study suggests

direct to your inboxThe Oxford/AstraZeneca Covid-19 vaccine is effective against the new variant of coronavirus discovered in the UK, a new study suggests.Oxford University researchers say the vaccine they developed has a similar efficacy against the new variant, compared with the original strain of Covid-19.Experts had been concerned about whether or not the vaccines currently being administered throughout the UK would be effective against the strain that emerged after trials had been conducted.The preprint also describes analysis which suggests vaccination with the Oxford/AstraZeneca jab results in a reduction in the duration of shedding and viral load, which may translate into a reduced transmission of the disease.Andrew Pollard,

Andrew Pollard Britain vaccine infection strain Coronavirus

News Oxford vaccine could stop Covid spread hailed as 'hugely encouraging' on GMB

Good Morning Britain 's Piers Morgan and Susanna Reid discussed on Wednesday's show a new study that suggests the Oxford-AstraZeneca Covid vaccine may reduce transmission of the virus by up to 67%.

Susanna Reid Piers Morgan Andrew Pollard Britain virus vaccine GMB

COVID-19 vaccine trials: Live updates

11/23/2020 09:52 GMT — AstraZeneca’s ‘Oxford’ vaccine 70% effectiveAccording to a recent press release, the experimental COVID-19 vaccine developed by AstraZeneca and Oxford University prevents just over 70% of people from developing COVID-19. Although this is lower than the Pfizer and Moderna vaccines, using a different dosing regimen may increase the protection to 90%.The recent announcement is based on data from 24,000 participants in three countries.

Andrew Pollard covid-19 vaccine prevention Updates

manchestereveningnews.co.uk

24.11.2020 / 00:45

42%

548

Everything the head of the Oxford vaccine project said about the jab at the coronavirus press conference

at a Downing Street press conference this evening, the Oxford Vaccine Group director Professor Andrew Pollard today hailed it as "very exciting day" and said he hoped it "will be part of what could be the end of the problems we're facing." "Our results today show that in our primary analysis, that the vaccine had 70 percent efficacy, which is fantastic" he said."That's high efficacy like we get with flu vaccines and has the potential to have a really important impact on the pandemic."Because we also, in the trials, saw no one go into hospital with severe disease or develop severe disease if they had been vaccinated."We also had these intriguing results you will have heard reported today where one arm of our study had much higher efficacy,

Andrew Pollard hospital vaccine Volunteers Coronavirus

What experts say on Oxford covid vaccine results

AstraZeneca said on Monday its vaccine for the novel coronavirus could be around 90% effective without any serious side effects, the latest drugmaker to unveil positive interim data in a scientific race to curb a global pandemic.Here are some reactions to the news:Professor Andrew Pollard, director of the Oxford vaccine group and chief investigator of the Oxford vaccine trial"These findings show that we have an effective vaccine that will save many lives.

Andrew Pollard covid-19 experts vaccine Coronavirus

AstraZeneca: COVID-19 vaccine 'highly effective' prevention

LONDON – AstraZeneca said Monday that late stage trials of its COVID-19 vaccine developed with Oxford University were “highly effective’’ in preventing disease.The results are based on interim analysis of trials in the U.K. and Brazil of the vaccine developed by Oxford University and manufactured by AstraZeneca.

Andrew Pollard Brazil covid-19 vaccine prevention

Today marks an important milestone: AstraZeneca CEO on Oxford covid vaccine

Covid-19 has shown "an average efficacy of 70 percent" in trials.Commenting on the findings, Pascal Soriot, Chief Executive Officer, said: “Today marks an important milestone in our fight against the pandemic.

Andrew Pollard Pascal Soriot covid-19 pandemic vaccine

Data shows Oxford vaccine 70% effective against Covid-19

A coronavirus vaccine developed by AstraZeneca and Oxford University can prevent 70.4% of people from getting Covid-19, data shows.

Andrew Pollard World Coronavirus

Millions of Covid-19 vaccines 'could be ready by Christmas', claims professor

coronavirus vaccines ready for production by the end of the year, a professor overseeing the trial claims. Chief investigator of the Oxford/AstraZeneca vaccine trial Professor Andrew Pollard says he is “optimistic” about getting approval on the jab by Christmas.He has said his team's “miracle” work has been done at “record speed”, adding that the vaccine is on the cusp of demonstrating “efficacy”.

Andrew Pollard covid-19 vaccine Government Coronavirus

Millions of UK-made coronavirus vaccines 'ready by Christmas', professor claims

Tens of millions of UK-made coronavirus vaccines will be ready for production by the end of the year, claims a professor overseeing the trial.

Andrew Pollard New York Britain covid-19 vaccine Government Coronavirus

'Small chance' Oxford Covid-19 vaccine will be ready by Christmas

The University of Oxford hopes to present late-stage trial results on its Covid-19 vaccine candidate this year though its top scientific investigator cautioned it would still take some time for life to return to normal.

Andrew Pollard Britain city Oxford vaccine World Coronavirus

Oxford coronavirus vaccine boss warns UK won't get back to normal until at least July

The boss involved in developing the Oxford vaccine has warned face masks and social distancing will still be needed until July.

Andrew Pollard Kate Bingham Britain mask infection Coronavirus

manchestereveningnews.co.uk

25.08.2020 / 18:19

44%

486

Oxford coronavirus vaccine could be put before regulators this year

coronavirus vaccine may have gathered enough safety and efficacy data by the end of the year, according to Professor Andrew Pollard, director of the Oxford Vaccine Group.

Chris Whitty Andrew Pollard covid-19 gatherings vaccine Coronavirus

Prince William Visits University Of Oxford To Learn More About Potential Coronavirus Vaccine

Prince William made a visit to the University of Oxford on Wednesday to learn more about their work to establish a viable vaccine against COVID-19.

Sarah Gilbert Andrew Pollard county Prince William county Oxford city Oxford hospital covid-19 vaccine Coronavirus

Coronavirus vaccine trial Phase 2 begins - who it involves and what it means for you

The second phase of the trial of the coronavirus vaccine tipped to be the ‘front runner’ in the fight against COVID-19 has started today.

Andrew Pollard city Oxford virus covid-19 vaccine Volunteers Coronavirus

Over 10,000 to receive potential COVID-19 vaccine in U.K. as studies advance

British researchers testing an experimental vaccine against the new coronavirus are moving into advanced studies and aim to immunize more than 10,000 people to determine if the shot works.

Andrew Pollard Britain covid-19 coronavirus news vaccine Coronavirus

COVID-19 vaccine hunt heats up globally, still no guarantee

WASHINGTON – Hundreds of people are rolling up their sleeves in countries across the world to be injected with experimental vaccines that might stop COVID-19, spurring hope — maybe unrealistic — that an end to the pandemic may arrive sooner than anticipated.

Andrew Pollard Washington city Oxford virus covid-19 testing vaccine

Coronavirus vaccine 'could be ready in six months' but widespread use could take longer

A vaccine for the coronavirus could be ready in six months a top scientist has revealed.

Andrew Pollard city Oxford testing Government

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0